BAP1/ASXL1 recruitment and activation for H2A deubiquitination

Nature Communications

Volumn 7, Issue , 2016, Pages

  Sahtoe, Danny D ^a   Van Dijk, Willem J ^a   Ekkebus, Reggy ^a   Ovaa, Huib ^a   Sixma, Titia K ^a  

^a NETHERLANDS CANCER INSTITUTE   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ASXL1 PROTEIN; BAP1 PROTEIN; DEUBIQUITINASE; HISTONE H2A; UBIQUITIN; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG; ASXL1 PROTEIN, HUMAN; BAP1 PROTEIN, HUMAN; HISTONE; REPRESSOR PROTEIN; TUMOR SUPPRESSOR PROTEIN;

ACTIVATED CARBON; EXPERIMENTAL STUDY; MOLECULAR ANALYSIS; RECRUITMENT (POPULATION DYNAMICS); TUMOR;

ARTICLE; DNA DAMAGE; ENZYME ACTIVITY; HISTONE UBIQUITINATION; NUCLEOSOME; PROTEIN DOMAIN; UBIQUITINATION; AMINO ACID SEQUENCE; CELL LINE; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; GENETICS; HUMAN; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; MOLECULAR MODEL; PHYSIOLOGY; PROTEIN CONFORMATION;

AMINO ACID SEQUENCE; CELL LINE; CLONING, MOLECULAR; ESCHERICHIA COLI; GENE EXPRESSION REGULATION; HISTONES; HUMANS; MODELS, MOLECULAR; MOLECULAR SEQUENCE DATA; PROTEIN CONFORMATION; REPRESSOR PROTEINS; TUMOR SUPPRESSOR PROTEINS; UBIQUITIN THIOLESTERASE;

EID: 84954136856     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms10292     Document Type: Article

References (53)

1. Carbone M., et al. BAP1 and cancer. Nat. Rev. Cancer 13, 153-159 (2013
2. Harbour J. W., et al. Frequent mutation of BAP1 in metastasizing uveal melanomas. Science 330, 1410-1413 (2010
3. Bott M., et al. The nuclear deubiquitinase BAP1 is commonly inactivated by somatic mutations and 3p21.1 losses in malignant pleural mesothelioma. Nat. Genet. 43, 668-672 (2011
4. Testa J. R., et al. Germline BAP1 mutations predispose to malignant mesothelioma. Nat. Genet. 43, 1022-1025 (2011
5. Wiesner T., et al. Germline mutations in BAP1 predispose to melanocytic tumors. Nat. Genet. 43, 1018-1021 (2011
6. Goldstein A. M. Germline BAP1 mutations and tumor susceptibility. Nat. Genet. 43, 925-926 (2011
7. Peña-Llopis S., et al. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44, 751-759 (2012
8. Dey A., et al. Loss of the tumor suppressor BAP1 causes myeloid transformation. Science 337, 1541-1546 (2012
9. Kandoth C., et al. Mutational landscape and significance across 12 major cancer types. Nature 502, 333-339 (2013
10. Yu H., et al. Tumor suppressor and deubiquitinase BAP1 promotes DNA double-strand break repair. Proc. Natl Acad. Sci. USA 111, 285-290 (2014
11. Lee H.-S., Lee S.-A., Hur S.-K., Seo J.-W., & Kwon J. Stabilization and targeting of INO80 to replication forks by BAP1 during normal DNA synthesis. Nat. Commun. 5, 5128 (2014
12. Eletr Z. M., & Wilkinson K. D. An emerging model for BAP1?s role in regulating cell cycle progression. Cell Biochem. Biophys. 60, 3-11 (2011
13. Misaghi S., et al. Association of C-terminal ubiquitin hydrolase BRCA1-associated protein 1 with cell cycle regulator host cell factor 1. Mol. Cell Biol. 29, 2181-2192 (2009
14. Ji Z., et al. The forkhead transcription factor FOXK2 acts as a chromatin targeting factor for the BAP1-containing histone deubiquitinase complex. Nucleic Acids Res. 42, 6232-6242 (2014
15. Baymaz H. I., et al. MBD5 and MBD6 interact with the human PR-DUB complex through their methyl-CpG-binding domain. Proteomics 14, 2179-2189 (2014
16. Francis N. J., Kingston R. E., & Woodcock C. L. Chromatin compaction by a polycomb group protein complex. Science 306, 1574-1577 (2004
17. Scheuermann J. C., et al. Histone H2A deubiquitinase activity of the Polycomb repressive complex PR-DUB. Nature 465, 243-247 (2010
18. Wang H., et al. Role of histone H2A ubiquitination in Polycomb silencing. Nature 431, 873-878 (2004
19. Gaytán De Ayala Alonso A., et al. A genetic screen identifies novel polycomb group genes in Drosophila. Genetics 176, 2099-2108 (2007
20. Balasubramani A., et al. Cancer-associated ASXL1 mutations may act as gain-of-function mutations of the ASXL1-BAP1 complex. Nat. Commun. 6, 7307 (2015
21. Pengelly A. R., Kalb R., Finkl K., & Müller J. Transcriptional repression by PRC1 in the absence of H2A monoubiquitylation. Genes Dev. 29, 1487-1492 (2015
22. Illingworth R. S., et al. The E3 ubiquitin ligase activity of RING1B is not essential for early mouse development. Genes Dev. 29, 1897-1902 (2015
23. Katoh M. Functional and cancer genomics of ASXL family members. Br. J. Cancer 109, 299-306 (2013
24. Hoischen A., et al. De novo nonsense mutations in ASXL1 cause Bohring-Opitz syndrome. Nat. Genet. 43, 729-731 (2011
25. Sahtoe D. D., et al. Mechanism of UCH-L5 Activation and Inhibition by DEUBAD Domains in RPN13 and INO80G. Mol. Cell 57, 887-900 (2015
26. VanderLinden R. T., et al. Structural basis for the activation and inhibition of the UCH37 deubiquitylase. Mol. Cell 57, 901-911 (2015
27. Sowa M. E., Bennett E. J., Gygi S. P., & Harper J. W. Defining the human deubiquitinating enzyme interaction landscape. Cell 138, 389-403 (2009
28. Clague M. J., et al. Deubiquitylases from genes to organism. Physiol. Rev. 93, 1289-1315 (2013
29. Sahtoe D. D., & Sixma T. K. Layers of DUB regulation. Trends Biochem. Sci. 40, 456-467 (2015
30. Sanchez-Pulido L., Kong L., & Ponting C. P. A common ancestry for BAP1 and Uch37 regulators. Bioinformatics 28, 1953-1956 (2012
31. Aravind L., & Iyer L. M. The HARE-HTH and associated domains: novel modules in the coordination of epigenetic DNA and protein modifications. Cell Cycle 11, 119-131 (2012
32. Dang L. C., Melandri F. D., & Stein R. L. Kinetic and mechanistic studies on the hydrolysis of ubiquitin C-terminal 7-amido-4-methylcoumarin by deubiquitinating enzymes. Biochemistry 37, 1868-1879 (1998
33. Yu H., et al. The ubiquitin carboxyl hydrolase BAP1 forms a ternary complex with YY1 and HCF-1 and is a critical regulator of gene expression. Mol. Cell Biol. 30, 5071-5085 (2010
34. Mattiroli F., et al. RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA damage signaling. Cell 150, 1182-1195 (2012
35. Gatti M., et al. A novel ubiquitin mark at the N-terminal tail of histone H2As targeted by RNF168 ubiquitin ligase. Cell Cycle 11, 2538-2544 (2012
36. El Oualid F., et al. Chemical synthesis of ubiquitin, ubiquitin-based probes, and diubiquitin. Angew. Chem. Int. Ed. Engl. 49, 10149-10153 (2010
37. Ekkebus R., et al. On terminal alkynes that can react with active-site cysteine nucleophiles in proteases. J. Am. Chem. Soc. 135, 2867-2870 (2013
38. Shanmugham A., et al. Nonhydrolyzable ubiquitin-isopeptide isosteres as deubiquitinating enzyme probes. J. Am. Chem. Soc. 132, 8834-8835 (2010
39. Ventii K. H., et al. BRCA1-associated protein-1 is a tumor suppressor that requires deubiquitinating activity and nuclear localization. Cancer Res. 68, 6953-6962 (2008
40. Mattiroli F., Uckelmann M., Sahtoe D. D., van Dijk W. J., & Sixma T. K. The nucleosome acidic patch plays a critical role in RNF168-dependent ubiquitination of histone H2A. Nat. Commun. 5, 3291 (2014
41. McGinty R. K., Henrici R. C., & Tan S. Crystal structure of the PRC1 ubiquitylation module bound to the nucleosome. Nature 514, 591-596 (2014
42. Kalashnikova A. A., Porter-Goff M. E., Muthurajan U. M., Luger K., & Hansen J. C. The role of the nucleosome acidic patch in modulating higher order chromatin structure. J. R. Soc. Interface 10, 20121022 (2013
43. Daou S., et al. The BAP1/ASXL2 histone H2A deubiquitinase complex regulates cell proliferation and is disrupted in cancer. J. Biol. Chem. M115, 661553 (2015
44. Mashtalir N., et al. Autodeubiquitination protects the tumor suppressor BAP1 from cytoplasmic sequestration mediated by the atypical ubiquitin ligase UBE2O. Mol. Cell 54, 392-406 (2014
45. Luna-Vargas M. P. A., et al. Enabling high-throughput ligation-independent cloning and protein expression for the family of ubiquitin specific proteases. J. Struct. Biol. 175, 113-119 (2011
46. Luger K., Rechsteiner T. J., & Richmond T. J. Expression and purification of recombinant histones and nucleosome reconstitution. Methods Mol. Biol. 119, 1-16 (1999
47. Dyer P. N., et al. Reconstitution of nucleosome core particles from recombinant histones and DNA. Methods Enzymol. 375, 23-44 (2004
48. Lowary P. T., & Widom J. New DNA sequence rules for high affinity binding to histone octamer and sequence-directed nucleosome positioning. J. Mol. Biol. 276, 19-42 (1998
49. Kramer H. B., Chalker J. M., & Davis B. G. Tristriazole ligand for use in the Cu-Catalyzed [3+2] azide-alkyne cycloaddition on protein surfaces. Protoc. Exch. (2007
50. Geurink P. P., El Oualid F., Jonker A., Hameed D. S., & Ovaa H. A general chemical ligation approach towards isopeptide-linked ubiquitin and ubiquitin-like assay reagents. Chembiochem 13, 293-297 (2012
51. Katoh K., & Toh H. Recent developments in the MAFFT multiple sequence alignment program. Brief. Bioinform. 9, 286-298 (2008
52. Landau M., et al. ConSurf 2005: the projection of evolutionary conservation scores of residues on protein structures. Nucleic Acids Res. 33, W299-W302 (2005
53. Krissinel E., & Henrick K. Secondary-structure matching (SSM), a new tool for fast protein structure alignment in three dimensions. Acta Crystallogr. D. Biol. Crystallogr. 60, 2256-2268 (2004